Potential role of ultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures

Richard J. Santen, Jennifer S. Lee, Shuping Wang, Lawrence M. Demers, Nelly Mauras, Hongkun Wang, Ravinder Jit Singh

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Radioimmunoassays (RIA) for the measurement of estradiol are sufficiently sensitive to assess the reproductive status of pre-menopausal women but lack sufficient sensitivity for low concentrations found in post-menopausal women. Bioassays have been used in the past to measure low estrogen levels but are impractical for handling high volumes of tests, particularly routine and non-research specimens. In this study, we compared results for estradiol using several different methods including bioassay, RIA, and two tandem mass spectrometry methods. At the lower tertile of estradiol measurements by RIA, the overall excellent correlation with results obtained by tandem mass spectrometry (i.e. r = 0.83) was lost (i.e. r = 0.29). In addition, results were much lower with bioassay and mass spectrometry than with RIA suggesting that RIA measures undesired noise or estrogen metabolites. The mass spectrometry methods correlate best with isotopic kinetic methods when assessing aromatase inhibition. On this basis, we conclude that mass spectrometry assays are the best option for measurement of low estradiol concentrations. With such assays, greater discrimination should be achievable when using estradiol levels as a predictor of the risks for breast cancer and for fractures.

Original languageEnglish (US)
Pages (from-to)1318-1321
Number of pages4
JournalSteroids
Volume73
Issue number13
DOIs
StatePublished - Dec 12 2008

Fingerprint

Radioimmunoassay
Mass spectrometry
Estradiol
Assays
Bioassay
Breast Neoplasms
Biological Assay
Mass Spectrometry
Tandem Mass Spectrometry
Estrogens
Aromatase
Metabolites
Noise
Kinetics

Keywords

  • Assay
  • Breast cancer
  • Estradiol
  • Fracture

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Molecular Biology
  • Organic Chemistry
  • Pharmacology

Cite this

Potential role of ultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures. / Santen, Richard J.; Lee, Jennifer S.; Wang, Shuping; Demers, Lawrence M.; Mauras, Nelly; Wang, Hongkun; Singh, Ravinder Jit.

In: Steroids, Vol. 73, No. 13, 12.12.2008, p. 1318-1321.

Research output: Contribution to journalArticle

Santen, Richard J. ; Lee, Jennifer S. ; Wang, Shuping ; Demers, Lawrence M. ; Mauras, Nelly ; Wang, Hongkun ; Singh, Ravinder Jit. / Potential role of ultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures. In: Steroids. 2008 ; Vol. 73, No. 13. pp. 1318-1321.
@article{5037e9ce9e504940b3db0e286d9efc9e,
title = "Potential role of ultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures",
abstract = "Radioimmunoassays (RIA) for the measurement of estradiol are sufficiently sensitive to assess the reproductive status of pre-menopausal women but lack sufficient sensitivity for low concentrations found in post-menopausal women. Bioassays have been used in the past to measure low estrogen levels but are impractical for handling high volumes of tests, particularly routine and non-research specimens. In this study, we compared results for estradiol using several different methods including bioassay, RIA, and two tandem mass spectrometry methods. At the lower tertile of estradiol measurements by RIA, the overall excellent correlation with results obtained by tandem mass spectrometry (i.e. r = 0.83) was lost (i.e. r = 0.29). In addition, results were much lower with bioassay and mass spectrometry than with RIA suggesting that RIA measures undesired noise or estrogen metabolites. The mass spectrometry methods correlate best with isotopic kinetic methods when assessing aromatase inhibition. On this basis, we conclude that mass spectrometry assays are the best option for measurement of low estradiol concentrations. With such assays, greater discrimination should be achievable when using estradiol levels as a predictor of the risks for breast cancer and for fractures.",
keywords = "Assay, Breast cancer, Estradiol, Fracture",
author = "Santen, {Richard J.} and Lee, {Jennifer S.} and Shuping Wang and Demers, {Lawrence M.} and Nelly Mauras and Hongkun Wang and Singh, {Ravinder Jit}",
year = "2008",
month = "12",
day = "12",
doi = "10.1016/j.steroids.2008.05.008",
language = "English (US)",
volume = "73",
pages = "1318--1321",
journal = "Steroids",
issn = "0039-128X",
publisher = "Elsevier Inc.",
number = "13",

}

TY - JOUR

T1 - Potential role of ultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures

AU - Santen, Richard J.

AU - Lee, Jennifer S.

AU - Wang, Shuping

AU - Demers, Lawrence M.

AU - Mauras, Nelly

AU - Wang, Hongkun

AU - Singh, Ravinder Jit

PY - 2008/12/12

Y1 - 2008/12/12

N2 - Radioimmunoassays (RIA) for the measurement of estradiol are sufficiently sensitive to assess the reproductive status of pre-menopausal women but lack sufficient sensitivity for low concentrations found in post-menopausal women. Bioassays have been used in the past to measure low estrogen levels but are impractical for handling high volumes of tests, particularly routine and non-research specimens. In this study, we compared results for estradiol using several different methods including bioassay, RIA, and two tandem mass spectrometry methods. At the lower tertile of estradiol measurements by RIA, the overall excellent correlation with results obtained by tandem mass spectrometry (i.e. r = 0.83) was lost (i.e. r = 0.29). In addition, results were much lower with bioassay and mass spectrometry than with RIA suggesting that RIA measures undesired noise or estrogen metabolites. The mass spectrometry methods correlate best with isotopic kinetic methods when assessing aromatase inhibition. On this basis, we conclude that mass spectrometry assays are the best option for measurement of low estradiol concentrations. With such assays, greater discrimination should be achievable when using estradiol levels as a predictor of the risks for breast cancer and for fractures.

AB - Radioimmunoassays (RIA) for the measurement of estradiol are sufficiently sensitive to assess the reproductive status of pre-menopausal women but lack sufficient sensitivity for low concentrations found in post-menopausal women. Bioassays have been used in the past to measure low estrogen levels but are impractical for handling high volumes of tests, particularly routine and non-research specimens. In this study, we compared results for estradiol using several different methods including bioassay, RIA, and two tandem mass spectrometry methods. At the lower tertile of estradiol measurements by RIA, the overall excellent correlation with results obtained by tandem mass spectrometry (i.e. r = 0.83) was lost (i.e. r = 0.29). In addition, results were much lower with bioassay and mass spectrometry than with RIA suggesting that RIA measures undesired noise or estrogen metabolites. The mass spectrometry methods correlate best with isotopic kinetic methods when assessing aromatase inhibition. On this basis, we conclude that mass spectrometry assays are the best option for measurement of low estradiol concentrations. With such assays, greater discrimination should be achievable when using estradiol levels as a predictor of the risks for breast cancer and for fractures.

KW - Assay

KW - Breast cancer

KW - Estradiol

KW - Fracture

UR - http://www.scopus.com/inward/record.url?scp=54149101289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54149101289&partnerID=8YFLogxK

U2 - 10.1016/j.steroids.2008.05.008

DO - 10.1016/j.steroids.2008.05.008

M3 - Article

C2 - 18614192

AN - SCOPUS:54149101289

VL - 73

SP - 1318

EP - 1321

JO - Steroids

JF - Steroids

SN - 0039-128X

IS - 13

ER -